INDUSTRY
Discover how we're helping companies deliver better patient outcomes through differentiated platforms, consulting, and operations services
Our patient survey research confirms that the coronavirus (COVID-19) will permanently change patient behavior, as well as the healthcare landscape.
MedTech companies can take swift action to help solve for the COVID-19 crisis with a mindset of agility and responsible innovation.
Accenture knows life science companies are at the center of the COVID-19 pandemic to develop tests & treatments for people in need.
Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.
We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.
New science: Biopharma’s new growth engine
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.
READ MOREAccenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.
View TranscriptAccenture Life Sciences offers a full range of services in Strategy, Consulting, Accenture Interactive, Operations and Technology that help deliver more personalized healthcare and better patient outcomes.
Accenture supports forces with Siemens Healthineers in digitizing its customer service processes.
Accenture helped a biopharma company implement a patient-centered platform to manage the delivery of a personalized gene therapy solution.
A new SAP S/4 HANA ERP solution ushers Merck KGaA Healthcare into a digital future.
Accenture's Patient Survey sets out changes in care during coronavirus and found a major shift to virtual care.
Discover four essential steps to gain widespread adoption of precision oncology.
Accenture research reveals how companies can navigate the impediments to the value and progress that digitalization can drive. Learn more.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
MICROSOFT
2020
EVEREST GROUP PEAK MATRIX REPORT
2020
EVEREST GROUP PEAK MATRIX REPORT
2019
We are proud to collaborate with leading women in Life Sciences in their quest to advance science and patient care.
Driven by a constant curiosity, Lisa Banks’ career has taken her many places, from starting out as a pharmacist in the UK, to moving halfway around the world to work in China, to now living and working in Belgium with her family. Currently Head of Digital Innovations for GSK Vaccines, Lisa is at the forefront of innovation, helping accelerate the identification and adoption of new technologies to support the full lifecycle of a vaccine – a timely role at a time when the world is faced with a pandemic. We sat down with Lisa to learn more about her career path, what drives her curiosity, and the importance of women in Life Sciences.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Accenture's blog explains how Clinical decision support tools in oncology will fundamentally change the way cancer patients are treated.
Accenture's Ray Pressburger explores how Customer Experience (CX) can drive value in the pharmaceutical industry.
Knowledge of trends and insights are important to Accenture. Join our live thought leader-hosted events and watch on-demand sessions.
Adapting to the future of clinical R&D
Patient-centric leadership in cell and gene therapy
Accenture is positioned as a Leader in medical devices digital services in a new report from independent research firm Everest Group.
Patients have embraced virtual care and communications at very high rates as a result of COVID-19.
Accenture is positioned as a leader in life sciences operations services in a new report from independent research firm Everest Group.
